异常粪便筛查后结肠镜检查时机与结直肠癌发病及死亡风险
该回顾性队列纳入1999–2010年间50–75岁粪便潜血或免疫化学检测异常且后续接受诊断性结肠镜的退伍军人204,733例,以1–3个月为参照,发现延迟至13–15个月起结直肠癌发病风险升高,19–24个月死亡风险升高,16个月后晚期癌风险增加。
要点
- 异常FIT/FOBT后13–15个月起结直肠癌发病风险已升高。
- 延迟至19–24个月结肠镜与结直肠癌死亡风险升高相关。
- 16个月后晚期结直肠癌诊断风险增加。
核心结论
- 异常FIT/FOBT后结肠镜延迟与结直肠癌发病、死亡及晚期诊断风险升高相关,应强调1年内完成诊断性随访。
研究设计与样本
- 回顾性队列研究,纳入1999–2010年50–75岁FOBT或FIT异常且接受诊断性结肠镜的退伍军人204,733例,平均年龄61岁(SD 6.9)。
主要发现
- 以1–3个月结肠镜为参照,13–15个月组结直肠癌发病HR 1.13(95%CI 1.00–1.27)。
- 16–18个月组结直肠癌发病HR 1.25(95%CI 1.10–1.43)。
- 19–21个月组结直肠癌发病HR 1.28(95%CI 1.11–1.48),死亡HR 1.52(95%CI 1.51–1.99)。
- 22–24个月组结直肠癌发病HR 1.26(95%CI 1.07–1.47),死亡HR 1.39(95%CI 1.03–1.88)。
- 16个月后晚期结直肠癌诊断的比值比升高。
临床怎么用
- 对FIT/FOBT异常者应在1年内完成诊断性结肠镜,以降低结直肠癌发病、死亡及晚期诊断风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: The optimal time interval for diagnostic colonoscopy completion after an abnormal stool-based colorectal cancer (CRC) screening test is uncertain. We examined the association between time to colonoscopy and CRC outcomes among individuals who underwent diagnostic colonoscopy after abnormal stool-based screening. METHODS: We performed a retrospective cohort study of veterans age 50 to 75 years with an abnormal fecal occult blood test (FOBT) or fecal immunochemical test (FIT) between 1999 and 2010. We used multivariable Cox proportional hazards to generate CRC-specific incidence and mortality hazard ratios (HRs) and 95% confidence intervals (CI) for 3-month colonoscopy intervals, with 1 to 3 months as the reference group. Association of time to colonoscopy with late-stage CRC diagnosis was also examined. RESULTS: Our cohort included 204,733 patients. Mean age was 61 years (SD 6.9). Compared with patients who received a colonoscopy at 1 to 3 months, there was an increased CRC risk for patients who received a colonoscopy at 13 to 15 months (HR 1.13; 95% CI 1.00-1.27), 16 to 18 months (HR 1.25; 95% CI 1.10-1.43), 19 to 21 months (HR 1.28; 95% CI: 1.11-1.48), and 22 to 24 months (HR 1.26; 95% CI 1.07-1.47). Compared with patients who received a colonoscopy at 1 to 3 months, mortality risk was higher in groups who received a colonoscopy at 19 to 21 months (HR 1.52; 95% CI 1.51-1.99) and 22 to 24 months (HR 1.39; 95% CI 1.03-1.88). Odds for late-stage CRC increased at 16 months. CONCLUSIONS: Increased time to colonoscopy is associated with higher risk of CRC incidence, death, and late-stage CRC after abnormal FIT/FOBT. Interventions to improve CRC outcomes should emphasize diagnostic follow-up within 1 year of an abnormal FIT/FOBT result.
引用
- San Miguel Y, Demb J, Martinez ME, et al. Time to Colonoscopy After Abnormal Stool-Based Screening and Risk for Colorectal Cancer Incidence and Mortality. Gastroenterology. 2021. PMID: 33545140. doi:10.1053/j.gastro.2021.01.219
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。